Navigation Links
FDA Places Politics Above Science, Women's Health, and Informed Consent

WASHINGTON, June 17 /PRNewswire-USNewswire/ -- This afternoon the Food and Drug Administration (FDA) Advisory Panel, considering the new "Emergency Contraceptive," Ella, which can also act as an abortifacient, voted against recommending ANY precautions or labeling that would inform women of the drug's abortifacient capabilities as well as health risks.

Jeanne Monahan, Family Research Council's Director of the Center for Human Dignity, released the following statement:

"The FDA is placing politics above science, women's health and informed consent. Family Research Council calls upon the Obama Administration and the FDA to make good on their promise of transparency and honesty. Women deserve to know that this drug can take a life that has already been implanted as well as the serious health risks it imposes, including infection and bleeding.  Women's health should not be jeopardized just to advance the agenda of the abortion industry."



SOURCE Family Research Council
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. RBC Life Sciences Ranked as One of the Top 100 Workplaces in the Dallas-Fort Worth Area
2. New Places and People - Truphatek opens USA subsidiary
3. Ochsner Replaces Heart Valve Without Open Heart Surgery
4. Merck/Gilead Once-A-Day AIDS Pill Not Available in Most Places - AHF Urges Speed-Up of Registrations
5. AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate
6. Benevolence Beyond Politics, Inc. Announces Position to Provide Financial and Logistical Support for Humanitarian and Medical Missions Worldwide
7. Veto of Californias Condoms in Prisons Bill: "Politics Over Public Health," Says AHF
8. International Merchant Advisors Completes All Stock Based Purchase of Medical Marijuana Company Organic Science, Inc.
9. OMNIlife science, Inc., Announces U.S. Distribution Agreement with SERF-Dedienne Sante of France for its ION free Large Diameter Head Dual Mobility Acetabular Cup System
10. Sensors for Medicine and Science, Inc. Names Dr. Paul Strumph as Chief Medical Officer
11. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
Post Your Comments:
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):